Literature DB >> 19064964

Cancer: the road to Amiens.

David J Stewart1, Razelle Kurzrock.   

Abstract

Mesh:

Year:  2008        PMID: 19064964     DOI: 10.1200/JCO.2008.18.9621

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  38 in total

1.  Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective.

Authors:  Ralph M Meyer; Heather A Stanton; Wendy R Parulekar; Fred Saad
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

Review 2.  Moving molecular targeted drug therapy towards personalized medicine: issues related to clinical trial design.

Authors:  Jaap Verweij; Maja de Jonge; Ferry Eskens; Stefan Sleijfer
Journal:  Mol Oncol       Date:  2012-02-16       Impact factor: 6.603

Review 3.  Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

Authors:  Filip Janku; David J Stewart; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

4.  A Patient Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles.

Authors:  Eric B Lynam; Jiin Leaw; Matthew B Wiener
Journal:  Drug Inf J       Date:  2012-07

5.  The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.

Authors:  Larissa A Meyer; Brian M Slomovitz; Bojana Djordjevic; Shannon N Westin; David A Iglesias; Mark F Munsell; Yunyun Jiang; Rosemarie Schmandt; Russell R Broaddus; Robert L Coleman; John M Galbincea; Karen H Lu
Journal:  Int J Gynecol Cancer       Date:  2014-05       Impact factor: 3.437

6.  Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.

Authors:  John Moroney; Jennifer Wheler; David Hong; Aung Naing; Gerald Falchook; Diane Bodurka; Robert Coleman; Karen Lu; Lianchun Xiao; Razelle Kurzrock
Journal:  Gynecol Oncol       Date:  2010-03-26       Impact factor: 5.482

7.  Factors related to biopsy willingness in patients with advanced cancer in a phase 1 clinic for molecularly targeted therapy.

Authors:  David S Hong; Goldy C George; Eucharia C Iwuanyanwu; Bahareh Tavana; Gerald S Falchook; Sarina A Piha-Paul; Jennifer J Wheler; Reena H Mistry; Xiudong Lei; Razelle Kurzrock
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-02       Impact factor: 4.553

Review 8.  Compliance in early-phase cancer clinical trials research.

Authors:  Razelle Kurzrock; David J Stewart
Journal:  Oncologist       Date:  2013-03-01

Review 9.  Combining targeted therapies: practical issues to consider at the bench and bedside.

Authors:  Jordi Rodon; Jose Perez; Razelle Kurzrock
Journal:  Oncologist       Date:  2010-01-15

10.  Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.

Authors:  Vassiliki Kotoula; Elpida Charalambous; Bart Biesmans; Andigoni Malousi; Eleni Vrettou; George Fountzilas; George Karkavelas
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.